The development comes during a time when GLP-1s continue to dominate conversations in the space, particularly when it comes to their capabilities for treating other indications
Many patients lose 1020% of their body weight while also improving: Blood sugar regulation Appetite control Blood pressure Overall metabolic health At Be Well Medical Group, we prescribe FDA-approved GLP-1 medications when appropriate and tailor treatment based on your goals, response, and tolerance
The post-war Syldavia may no longer be a monarchy
Retatrutide causes significant fat loss but also some lean mass loss if protein intake and training are not managed
While injection-site irritation is well recognized, clinicians are increasingly observing broader skin changes in patients treated with semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), and tirzepatide Read More GLP-1s and Dermatologic Reactions: Beyond Injection-Site Effects Dermatologic reactions linked to GLP-1 therapy are gaining attention as the use of glucagon-like peptide-1 receptor agonists continues to expand in diabetes and obesity care
February 18, 2026: Ozempic Manufacturer Runs $20 Million Super Bowl Ad Despite Mounting Lawsuits Novo Nordisk, which makes the GLP-1 drugs Ozempic and Wegovy, aired a high-profile ad during Super Bowl LX that reportedly cost more than $20 million
